课题基金 / 基金详情

Mechanism of Autophagic Action of Type I Human Interferon

Mechanism of Autophagic Action of Type I Human Interferon
I型人干扰素的自噬作用机制
批准号:
8946534
负责人:
Kathryn Zoon
金额:
$15.02万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

Kathryn Zoon的其他基金

相似基金

相关文献

中文摘要
翻译
I型IFN从24小时开始诱导Daudi细胞的自噬,自噬标志物LC 3-II、Atg 5-Atg 12复合物的增加和p62的减少表明了这一点。在HeLa S3、MDA-MB-231、T98 G和A549细胞系中,IFN-α 2c处理后48小时也检测到更高水平的LC 3-II。自噬标记物表达的增加与Daudi细胞中mTORC 1活性的抑制相关。许多信号通路在mTORC 1的调节中发挥作用(例如PI 3 K、AKT)。 用IFN-α 2c与雷帕霉素(mTORC 1抑制剂)或LY 294002(PI 3 K抑制剂)组合处理Daudi和T98 G细胞增加了LC 3-II的水平,表明PI 3 K/AKT/mTORC 1信号通路可能影响Daudi和T98 G细胞中IFN诱导的自噬。通过siRNA敲低实验证实了mTOR和mTOR上游因子在I型IFN诱导的自噬中的作用。使用透射电子显微镜显示自噬体的存在。总之,我们的研究结果证明了一种新的功能,I型干扰素作为诱导剂的自噬在各种癌细胞系。
英文摘要
Type I IFN induces autophagy in Daudi cells starting at 24 h as indicated by an increase of autophagy markers LC3-II, Atg5-Atg12 complexes, and a decrease of p62. Higher levels of LC3-II were also detected 48 h post IFN-alpha2c treatment in HeLa S3, MDA-MB-231, T98G and A549 cell lines. The increase in expression of autophagy markers correlated with inhibition of mTORC1 activity in Daudi cells. Many signaling pathways play a role in regulation of mTORC1 (e.g. PI3K, AKT). Treatment of Daudi and T98G cells with IFN-alpha2c in combination with either rapamycin (mTORC1 inhibitor) or LY294002 (PI3K inhibitor) increased the level of LC3-II, indicating that the PI3K/AKT/mTORC1 signaling pathway may affect IFN-induced autophagy in Daudi and T98G cells. The role of mTOR and factors upstream of mTOR in Type I IFN-induced autophagy was confirmed by siRNA knockdown experiments. The presence of autophagosomes was shown using transmission electron microscopy. In conclusion, our findings demonstrate a novel function of Type I IFN as an inducer of autophagy in a variety of cancer cell lines.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of Antitumor Action of Human Interferon
Novel Human Interferons Produced by Protein Engineering
Evasion of Host Immune Response by Dengue Virus
Novel Human Interferons Produced by Protein Engineering
海外基金